3M Stock Prediction and Forecast [MMM]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 25 Oct 2025, 03:44 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for 3M Stock Prediction and Forecast [MMM]](https://i.ytimg.com/vi/38iTClxEMYQ/hqdefault.jpg)
AI-generated source summary
The analysis focuses on 3M stock (MMM), identifying a buy signal based on short and long-term moving averages. On October 24th, 2025, the score was 2.06, categorizing it as a buy candidate. The stock is currently trading at $168.50. It resides in the upper section of a broad rising trend and suggests selling opportunities for short-term traders, expecting a reaction to the lower trend. There are resistance levels at $171.60 and $172.85. A suggested stop-loss is at $161.14. A potential change of 4.45% is expected over the next three months, with a potential range from -7.08% to 6.44%. The 12-month projection indicates a 19.05% change. The 100 recent insider trading data show buys for 138288 shares and sell is 174090. The average analyst rating is neutral and it open undervalued.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.